Industry Research by Koncept Analytics
The US Specialty Pharmaceutical Market: Industry Analysis & Outlook ----------------------------------------(2017-2021) December 2017
The US Specialty Pharmaceutical Market: Industry Analysis & Outlook (2017-2021)
1
Executive Summary The US pharmaceutical market is segregated into two types of drugs majorly i.e. traditional drugs and specialty drugs. Specialty drugs in recent times have gained a strong foothold in the US and are likely to experience robust growth in the coming years, with majority of the pharmaceutical companies heading their research and development initiatives towards these drugs. Specialty drugs are basically meant for chronic and rare disease. Drugs in this category are very expensive and difficult to administer. Also, these drugs require proper management and special handling making them costly. Since, a large part of population in the US is ageing into diseases like cancer, and other deadly diseases, the demand for specialty drugs has skyrocketed in recent times. The US specialty pharmaceutical market has changed over the span of five years with a lot of these drugs being in their final phase of development. The US specialty pharmaceutical market is likely to grow at staggering growth rate in the coming years majorly due to factors like ageing population of the US, improving life expectancy, rise in real net per capita medicine spending on specialty drugs, and high prevalence of chronic disease in the region. The market is also undergoing some notable changes that have been covered in the report. The market growth is likely to be hindered by abandonment rate of specialty medicines and high R&D costs. The report offers an indepth analysis of the “The US Specialty Pharmaceutical Market: Industry Analysis & Outlook (2017-2021)�. Major pharmaceutical companies that have been covered in the report include Celgene Corporation, Gilead Sciences Inc., Amgen Inc., AbbVie Inc.. The US Specialty Pharmaceutical Market: Industry Analysis & Outlook (2017-2021)
2
There are a number of factors that aided growth of US specialty drugs market, but drug price was a key factor, which resulted in increased revenues. The US Pharmaceutical Market by Value (2012-2016)
The US Pharmaceutical Market by Segment Forecast (2021)
•
The US pharmaceutical market was recorded at US$.. billion in 2016, increasing from US$.. billion in the previous fiscal year. The market over the span of five years grew at a CAGR of ..% for the period spanning 2012-2016.
•
Specialty drugs are expected to account for ..% of the market revenues in the US in year 2021. This share is likely to increase by ..% from 2016.
•
In 2016, FDA approved ..% of new molecules in the specialty drugs category amongst which ..% were from xx segment. The remaining ..% drug approvals or new molecule base was of traditional drugs.
The US Pharmaceutical Market’s Drug Approval by Segment (2016)
The US Specialty Pharmaceutical Market: Industry Analysis & Outlook (2017-2021)
3
The US pharmaceutical market is expected to see a continuous shift from traditional drugs to specialty drugs. The US Specialty Pharmaceutical Market by Value (2012-2016)
The US Specialty Medication Prescription Volume (2012-2016)
•
The specialty pharmaceutical market was valued at US$.. billion in 2016, increasing from US$.. billion in 2012. The market grew at a CAGR of ..% for the period spanning 2012-2016.
•
The total prescription volume of specialty drugs in the US is anticipated to reach .. million mark by 2021, increasing from .. million in 2017.
•
Oncology is expected to remain on the top with the prescription volume anticipated to reach billion mark by 2021, followed by MS with total prescription volume reaching million.
The US Specialty Medication Prescription Volume Forecast by Therapeutic Class (2021)
The US Specialty Pharmaceutical Market: Industry Analysis & Outlook (2017-2021)
4
Contact Us:
Disclaimer
This is a licensed product of Koncept Analytics. You cannot reproduce, publish, distribute, publicly display, sell or create other works from this report or use them in any way for commercial purpose without our prior permission. Further, you cannot copy this material, by any means (including electronic copies), for distribution to others unless you have purchased the corporate license of this report. We believe the sources are reliable, but Koncept Analytics does not warranty the accuracy or completeness of the data. The data presented in the report is updated at the publication date but is subject to change at subsequent releases. All possible efforts have been made to ensure accuracy of data. However, investors should not completely rely on the information given in this report and must make decisions based on their own investment strategy, risk management and capital adequacy.
For Report Purchase Click Below: http:// www.konceptanalytics.com/Researchreport/the-us-specialty-pharmaceutical-market-industry-analysis-outlook-2017-2021 -29471.aspx
Koncept Analytics CS-36, First Floor, Ansal Plaza Vaishali, Ghaziabad, U.P. – 201010 T: +91-120-4130959 M: +91-9871694789 vikas@konceptanalytics.com www.konceptanalytics.com